Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/04/2013EP2668165A1 Novel tetrahydroquinoline derivatives
12/04/2013EP2668164A1 Novel azacoumarin derivatives having mdr pump inhibiting activity
12/04/2013EP2668162A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
12/04/2013EP2668160A1 Trpm8 receptor antagonists
12/04/2013EP2668159A1 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
12/04/2013EP2668157A1 Protease activated receptor 2 (par2) antagonists
12/04/2013EP2667945A1 Oil compositions
12/04/2013EP2667882A1 Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals
12/04/2013EP2667878A1 Compositions and methods for cell transplantation
12/04/2013EP2667877A2 Androgen composition for treating an ophthalmic condition
12/04/2013EP2667876A2 Methods and compounds for preparing 3alpha-oxygen substituted steroids
12/04/2013EP2667875A1 Compositions comprising a prostaglandin for treating neuropsychiatric conditions
12/04/2013EP2667874A2 Inhibitors of mtor kinasa as anti- viral agents
12/04/2013EP2667873A1 Small molecule rnase inhibitors and methods of use
12/04/2013EP2667872A2 Small molecule rnase inhibitors and methods of use
12/04/2013EP2667871A1 Combinations
12/04/2013EP2667870A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013EP2667869A1 Use of potassium channel blockers to treat cerebral palsy
12/04/2013EP2667868A2 Bendamustine formulations
12/04/2013EP2667867A1 Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
12/04/2013EP2667866A1 Use of (s) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder
12/04/2013EP2667865A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
12/04/2013EP2667864A2 Methods and compositions for treating kidney disorders
12/04/2013EP2667863A1 Local anaesthetic
12/04/2013EP2667862A1 Use of nicotinic acetylcholine receptor alpha 7 activators
12/04/2013EP2667861A2 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
12/04/2013EP2667857A1 A drug delivery device
12/04/2013EP2667856A1 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
12/04/2013EP2667855A1 Drug delivery systems
12/04/2013EP2667853A1 Liposome and personal care composition comprising thereof
12/04/2013EP2667852A1 Adjuvant nanoemulsions with crystallisation inhibitors
12/04/2013EP2667851A1 Testosterone formulations
12/04/2013EP2667717A2 6-amino-2-substituted-5-vinylsilylpyrimidine-4-carboxylic acids and esters and 4-amino-6-substituted-3-vinylsilylpyridine-2-carboxylic acids and esters as herbicides
12/04/2013EP2667715A1 Treatment of autism spectrum disorderes using glycyl-l-2-methylprolyl-l-glutamic acid
12/04/2013EP2667713A1 Process for the preparation of 4-amino-3-chloro-5-fluoro-6-(substituted)picolinates
12/04/2013EP2667711A1 Remedy for migraine headache
12/04/2013EP2667709A1 Histone deacetylase inhibitors and compositions and methods of use thereof
12/04/2013EP2526100B1 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
12/04/2013EP2515897B1 A combination for the treatment of osteoarthritis
12/04/2013EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/04/2013CN203315382U Senile plaque removal plaster easy and convenient to use
12/04/2013CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications
12/04/2013CN1480212B Application of neurotoxin therapy in treatment of urinary system and relative diseases
12/04/2013CN103429607A C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
12/04/2013CN103429595A Inhibitors of hiv replication
12/04/2013CN103429593A Imidazo pyrazines
12/04/2013CN103429592A 6-substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment of hyperproliferative disorders
12/04/2013CN103429591A 6 substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in treatment of hyperproliferative disorders
12/04/2013CN103429590A 1,4 thiazepines/sulfones as BACE1 and/or BACE2 inhibitors
12/04/2013CN103429589A Oxazine derivatives and their use in the treatment of neurological disorders
12/04/2013CN103429588A Crystalline oxazine derivative and its use as bace inhibitor
12/04/2013CN103429587A New azaspirodecanone compounds as HSL inhibitors
12/04/2013CN103429586A Piperazinedione compounds
12/04/2013CN103429585A Indazolyl triazole derivatives as irak inhibitors
12/04/2013CN103429583A Triazole derivatives as WNT signaling pathway inhibitors
12/04/2013CN103429582A MST1 kinase inhibitors and method of use thereof
12/04/2013CN103429575A Fe(III) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
12/04/2013CN103429574A Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
12/04/2013CN103429572A Tetrasubstituted cyclohexyl compounds as kinase inhibitors
12/04/2013CN103429571A Substituted pyridines as sodium channel blockers
12/04/2013CN103429569A New azaspirodecanone compounds
12/04/2013CN103429266A A drug delivery device
12/04/2013CN103429262A Overcoming resistance to ERBB pathway inhibitors
12/04/2013CN103429249A Method for producing polygonum tinctorium extract
12/04/2013CN103429247A Treatment of erectile dysfunction and other indication
12/04/2013CN103429246A Delivery of treatment transdermally for fungal infection and other indication
12/04/2013CN103429245A Methods and compositions for inhibition of polymerase
12/04/2013CN103429244A Fused aminodihydrothiazine derivatives
12/04/2013CN103429243A Cdk抑制剂 Cdk inhibitors
12/04/2013CN103429242A Method and composition for prevention and treatment of cardiac hypertrophy
12/04/2013CN103429241A Gene cluster for biosynthesis of cycloclavine
12/04/2013CN103429240A Methods for increasing mean corpuscular volume
12/04/2013CN103429239A Methods for increasing reticulocyte hemoglobin content
12/04/2013CN103429238A Anticancer therapy with dual aurora kinase / MEK inhibitors
12/04/2013CN103429237A Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
12/04/2013CN103429236A Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
12/04/2013CN103429234A Use of jasmonate to treat bladder dysfunction
12/04/2013CN103429233A Transdermal delivery system containing galantamine or salts thereof
12/04/2013CN103429231A Novel preparation of an enteric release system
12/04/2013CN103429225A Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
12/04/2013CN103429224A Pharmaceutical composition for treating disease in oral cavity comprising rebamipide
12/04/2013CN103429223A Orally dispersible tablet
12/04/2013CN103429096A Stevia preparation
12/04/2013CN103429082A Process for the preparation of 4-amino-3-chloro-5-fluoro-6-(substituted)picolinates
12/04/2013CN103429079A Histone deacetylase inhibitors and compositions and methods of use thereof
12/04/2013CN103421832A Preparation and application of egg yolk antibody containing florfenicol drug resistance gene protein
12/04/2013CN103421706A Streptomyces, novel compounds, preparation methods of novel compounds and application of novel compounds in preparing anti-bacterial drugs and antineoplastic drugs
12/04/2013CN103421085A Oligopeptide used for increasing solubilities of paclitaxel or similar medicines based on paclitaxel structure
12/04/2013CN103421069A Fulvestrant phosphate derivative and preparation method and application thereof
12/04/2013CN103421068A Heteroaryl phosphamide compounds with antiviral activity
12/04/2013CN103421067A Double-target drug for anti-platelet aggregation and applications thereof
12/04/2013CN103421061A Lenalidomide derivative and preparation method and pharmaceutical application thereof
12/04/2013CN103421057A Combretastatin amino sugar conjugate and preparation method and medical appliance thereof
12/04/2013CN103421056A Dioxane derivatives modified by glucosamine, preparation method and applications thereof
12/04/2013CN103421049A Novel ni complex and its derivatives, producing method, and the use thereof as antioxidant
12/04/2013CN103421028A Vinorelbine derivative, medicine composition thereof, and preparation method and application of derivative and medicine composition
12/04/2013CN103421027A Preparation method and application method of diazabicyclo compound
12/04/2013CN103421021A Compound divorced from gamboge resin, derivative of compound, and pharmaceutical composition containing compound and derivative
12/04/2013CN103421011A Method for preparing sitagliptin phosphate anhydrous crystal form I
12/04/2013CN103421010A Pteridinone derivative as EGFR inhibitor and application thereof
1 ... 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 ... 7860